Vicente LLP Federal and International Cannabis and Psychedelics Law and Policy Update: February 2024
Feb 20, 2024
Federal and international law and policy insights, news and events from Vicente LLP
Feb 20, 2024
Federal and international law and policy insights, news and events from Vicente LLP
By Jason Adelstone
Jan 30, 2024
On August 29, 2023, the Department of Health and Human Services (“HHS”) sent the Drug Enforcement Administration (“DEA”) its recommendation to move marijuana from Schedule I to Schedule III of the Controlled Substances Act (“CSA”). Since then, the marijuana industry has waited in suspense for the DEA to make the final call as to what schedule marijuana will be placed. Read this Insights post that outlines the complex process of marijuana rescheduling in the US and outlines the key steps involved, from rule publication to review and final rule, emphasizing the critical role of stakeholder engagement in securing a Schedule III classification.
Nov 10, 2023
Federal and international law and policy insights, news and events from Vicente LLP.
By Shawn Hauser
Aug 31, 2023
The federal government formally acknowledged the medical use and low potential of abuse for cannabis, with the US Department of Health and Human Services recommending that cannabis be rescheduled to Schedule III under the Controlled Substances Act. While placement in Schedule III still criminalizes commercial cannabis activity at the federal level, it is a significant step on the path to ending prohibition. This rescheduling would eliminate the application of 280E tax penalties, reduce the level of criminal liability for cannabis-related activity, reduce barriers to research, legitimize the industry through gaining credibility and engagement by physicians and the medical community, and support a growing industry for the American economy.
By Katelin Edwards, Andrea Golan
Aug 1, 2023
Between an unfavorable court ruling and an uninspiring 2021 legislative session, not to mention a major drought impacting all Texas crops, things were not looking good for hemp in Texas going into the 2023 legislative session. Then, many of the promising bills introduced in the 2023 legislative session were unsuccessful. Where does the Texas hemp market go from here? Read this article for four predictions from Vicente's hemp team.
By Shane Pennington
Apr 4, 2023
Cannabis researchers can study the dispensary strains and products people are actually using around the country right now... without violating federal law… and without Congress lifting a finger. Read this article for two simple tricks to do so.
By Shane Pennington
Mar 1, 2023
How TGA's rescheduling of psilocybin and MDMA shines a bright light on DEA delinquency
Jan 19, 2023
Join Shane Pennington on February 1 for a Cannabis Business Times webinar discussing the opportunities and challenges surrounding the federally legal cannabis seeds market.
By Shane Pennington
Nov 9, 2022
What outcomes are possible from the impending administrative process to reconsider cannabis’s schedule I status? What are the implications of those various possible outcomes? And how should we all proceed in light of it all?
By Shane Pennington
Oct 21, 2022
To appreciate the gravity of the President’s scheduling directive and what could happen next, you need to understand (1) how the administrative process the President has set in motion will actually work and (2) how the agencies in charge have used it to affirm and reaffirm cannabis’s schedule I1 status repeatedly throughout the Comprehensive Drug Abuse Prevention and Control Act of 1970’s (“CSA”) history. Those topics are covered in this article.
By Shane Pennington
Oct 21, 2022
President Biden’s scheduling directive is enormously important. In fact, if permitted to run its course, it could revolutionize federal drug control law to a far greater degree than any of the many pending cannabis legalization bills.
Jul 28, 2022
Update on hemp-related legislation and rulemaking, regulatory changes, and other noteworthy hemp news and events.
Apr 14, 2022
Update on the lawsuit HIA & RE Botanicals, Inc v. DEA and why this case is critical to the hemp industry's future.
Apr 4, 2022
Update on hemp-related legislation and rulemaking, regulatory changes, and other noteworthy hemp news and events.
Mar 4, 2022
VS counsel Shane Pennington is joining Dr. Sue Sisley and attorney Matt Zorn on Tuesday, March 15 at 10 a.m. CT for the SXSW session "Sue 'n the DEA: Breaking the 50-year NIDA Monopoly."
By Shane Pennington
Nov 4, 2021
The NIDA monopoly on cultivating cannabis for research ended in May 2021. Researchers can now study cannabis from state-legal markets by getting it from one of DEA's newly-licensed cannabis cultivators.
By Shane Pennington
Oct 18, 2021
An introduction to the different registrations available for schedule I substances such as psilocybin and psilocin.
By Shane Pennington
Sep 13, 2021
Texas has allowed hemp cultivation and state-based manufacturing, distribution, and retail sale of hemp and consumable hemp products since 2019—but only if the products weren’t intended for smoking. This prohibition on a product with such high value for hemp farmers—and soaring consumer demand—was sure to make waves.
Aug 25, 2021
Vote for the panel "Sue 'n the DEA: Breaking the 50-Year NIDA Monopoly," featuring Shane Pennington to be included in SXSW 2022!
Aug 25, 2021
Vote for the panel "Sue 'n the DEA: Breaking the 50-Year NIDA Monopoly," featuring Shane Pennington to be included in SXSW 2022!
By Dwight Clark, Shawn Hauser, Jerrico Perez
May 18, 2021
Championing medical cannabis legislation would likely help Republican lawmakers attract younger supporters, appeal to more unaffiliated voters, and remain competitive.
Apr 23, 2021
Shawn Hauser and Jerrico Perez are slated to moderate two can't-miss discussions with Beto O'Rourke and Joe Jaworski on April 27 and 28 during Willie Nelson's first annual Luck Summit.
By Shawn Hauser
Mar 23, 2021
While we move closer to federal legalization, the great state of Texas remains an untapped major market—ripe for reform, but hard to move. Read this for opportunities to help bring about more responsible cannabis policies in the Lone Star State.
Mar 1, 2021
On March 6, 2021, Andrew Livingston will participate in the virtual event "Economics of a Regulated Cannabis Market," presented by the nonprofit cannabis advocacy organization Foundation for an Informed Texas.
By Vicente Sederberg LLP
Dec 1, 2020
For our 10th anniversary, we take a look back at VS's history of leadership in cannabis law, the marijuana and hemp industries, and drug policy reform.
By Andrew Livingston, Shawn Hauser, Dwight Clark, Mason Tvert
Oct 21, 2020
Texas could see more than half a billion dollars in annual tax revenue and tens of thousands of new jobs if it legalizes cannabis, a VS analysis finds.
By Shawn Hauser
May 19, 2020
With its incredible farming communities, over 100 million acres of farmland, and large manufacturing and research infrastructure, Texas is poised to play a significant role in the U.S. hemp industry.
Apr 20, 2020
Shawn Hauser and Dwight Clark talked about SBA loans for cannabis businesses and political advocacy during Texas NORML's 420 Stream-A-Thon.
Apr 17, 2020
Vicente Sederberg is monitoring the potential impact of the coronavirus (COVID-19) on hemp businesses, service providers, and consumers.
Mar 18, 2020
Vicente Sederberg LLP partner Shawn Hauser participated in Texas NORML's "State of Cannabis 2020." Watch it here!
Mar 12, 2020
Vicente Sederberg LLP has been working hard for many years to shape cannabis policy reform in Texas... and now we're pleased to announce that we've opened an office in Austin!
By Shawn Hauser, Partner; Courtney Barnes, Associate Attorney; Caitlin Wightman, Law Clerk
Jul 30, 2019
Here are five reasons why Texas is positioned to become one of the top hemp producers and researchers in the US, and potentially internationally.